The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains. Zakria D, Shah M, Rosenberg A, Burshtein J, et al. Dermatol Online J 2026;32.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zakria D, Shah M, Rosenberg A, Burshtein J, et al. The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains. Dermatol Online J 2026;32.
PMID: 42522480